Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Inhibitors of Na+/H+ exchange remain a focus of research at Aventis

June 5, 2000

Vivus seeks E.U. marketing approval for Alibra

June 1, 2000

Australian researchers discover novel conotoxin peptides that inhibit neuronal amine transporters

May 31, 2000

CVT-124 assessed in cirrhotic patients with ascites

May 29, 2000

Senetek acquires rights to novel compounds for topical treatment of sexual dysfunction

May 26, 2000

VPA-985 useful in hyponatremia

May 25, 2000

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Two new series of PDE5 inhibitors claimed by Pfizer

May 19, 2000

New class of peptides useful as selective alpha1-adrenoceptor antagonists

May 18, 2000

FDA requests additional animal data for Vasomax

May 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...